This grant is aimed at supporting Medications Development Centers of Excellence for research on safe and effective treatments for substance use disorders, focusing on both approved and investigational products. The emphasis is on clinical research to identify, evaluate, and develop medications and biologics. The centers may include a translational component to support the rationale for testing medications. The closing date for applications is August 15, 2013.
Opportunity ID: 231914
General Information
| Document Type:: | Grants Notice |
| Funding Opportunity Number:: | RFA-DA-14-004 |
| Funding Opportunity Title:: | Medications Development Centers of Excellence Cooperative Program (U54) |
| Opportunity Category:: | Discretionary |
| Opportunity Category Explanation:: | |
| Funding Instrument Type:: | |
| Category of Funding Activity:: | Education |
| Category Explanation:: | |
| Expected Number of Awards:: | 2 |
| CFDA Number(s):: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement:: | No |
| Version:: | Synopsis 1 |
| Posted Date:: | Apr 26, 2013 |
| Last Updated Date:: | |
| Original Closing Date for Applications:: | Aug 15, 2013 |
| Current Closing Date for Applications:: | Aug 15, 2013 |
| Archive Date:: | Sep 15, 2013 |
| Estimated Total Program Funding:: | $ 3,000,000 |
| Award Ceiling:: | $1,000,000 |
| Award Floor:: | $ |
Eligibility
| Eligible Applicants:: | Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility:: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name:: | National Institutes of Health |
| Description:: | This FOA solicits Specialized Center Cooperative Agreement (U54) applications to provide support for Medications Development Centers of Excellence (MDCE) with emphasis on clinical research directed towards the identification, evaluation, and development of safe and effective medications and biologics for treatment of substance use disorders (SUDs). Research may focus on both currently approved or novel, investigational products. Centers may have a translational component to reinforce rationale of medications for testing. |
| Link to Additional Information:: | |
| Grantor Contact Information:: | If you have difficulty accessing the full announcement electronically, please contact: |